Form 4: Omada Health CEO Sean Duffy Sells Shares

Omada Health CEO Sean P. Duffy reported transactions involving the sale of company common stock, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Sean P. Duffy, Chief Executive Officer of Omada Health, Inc. (OMDA), has reported several transactions involving the sale of the company's common stock.
• These sales occurred between June 24, 2026, and June 26, 2026.
• The transactions were conducted under a Rule 10b5-1 trading plan adopted by Mr. Duffy on March 13, 2026.
• The total number of shares sold across these transactions is 16,958.
• The weighted average sale prices ranged from $19.00 to $20.90 per share.
• Following these transactions, Mr. Duffy's direct beneficial ownership of Omada Health common stock is 394,603 shares.
• Additionally, Mr. Duffy indirectly beneficially owns 851,659 shares held in family trusts for the benefit of his family members, though he disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative sentiment due to the CEO selling shares, despite the sales being conducted under a pre-arranged plan.

Positives

• The sales were executed under a Rule 10b5-1 trading plan, which is designed to provide an affirmative defense against allegations of insider trading by establishing a pre-arranged plan for stock sales.
• The reporting person (Sean P. Duffy) continues to hold a significant number of shares directly (394,603) and indirectly (851,659), indicating continued investment in the company.

Negatives

• The CEO has sold a notable number of shares (16,958) over a short period.
• The sales represent a reduction in the CEO's direct holdings.

Risks

• Potential for negative market perception due to insider selling, even if conducted under a 10b5-1 plan.
• The specific reasons for adopting the 10b5-1 plan and the ongoing sales are not detailed, which could lead to speculation about the CEO's confidence in future stock performance.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

Industry Context

StockSavvy.ai notes that insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a signal of reduced confidence, although the existence of the plan itself is a mitigating factor against accusations of opportunistic trading.

Stakeholder Impact

• Shareholders may view the CEO's stock sales with caution, potentially impacting short-term stock price sentiment.
• Employees with stock options or grants may be concerned about the CEO's perceived confidence in the company's future stock performance.

Next Steps

• Continued monitoring of Sean P. Duffy's beneficial ownership and any future transactions.
• Analysis of Omada Health's overall financial performance and strategic developments to contextualize insider trading activity.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Beneficial Ownership, CEO, Sean P. Duffy, Securities Exchange Act